Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    Temporal arteritis
Show Display Options
Rank Status Study
1 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
2 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
3 Not yet recruiting Aetiology of TemporaL Arteritis Study
Condition: Temporal Arteritis
Intervention:
4 Recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
5 Terminated A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Infliximab
6 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
7 Unknown  Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Prednisone therapy and pharmacokinetic
8 Completed Hydroxychloroquine in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: hydroxychloroquine/placebo
9 Completed Tocilizumab for Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Tocilizumab + Glucocorticoids (GCs);   Drug: Placebo + Glucocorticoids (GCs)
10 Recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
11 Recruiting Biomarkers in Giant Cells Arteritis
Condition: Giant Cells Arteritis
Interventions: Behavioral: Clinical evaluation;   Other: Paraclinical evaluation;   Device: Imaging;   Other: Ophthalmologic examination;   Biological: Dosage of biomarkers
12 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
13 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
14 Completed HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: adalimumab;   Drug: placebo
15 Not yet recruiting Giant Cell Arteritis and Anakinra Trial
Condition: Giant Cell Arteritis
Interventions: Drug: PLACEBO;   Drug: ANAKINRA
16 Not yet recruiting Ustekinumab for the Treatment of Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Temporal Arteritis;   Horton's Disease
Interventions: Drug: Ustekinumab;   Drug: Prednisone
17 Active, not recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: prednisone;   Drug: prednisone placebo;   Drug: tocilizumab [RoActemra/Actemra];   Drug: tocilizumab placebo
18 Completed Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis
Interventions: Drug: Abatacept;   Drug: Placebo
19 Completed Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries;   Procedure: Temporal artery biopsy
20 Completed Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: methotrexate;   Drug: prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.